Skip to Content

1,192 Results Found

  • Article
  • Open Access
17 Citations
4,626 Views
12 Pages

Compaction Behavior of Co-Amorphous Systems

  • Cecilie-Mathilde Sørensen,
  • Jukka Rantanen and
  • Holger Grohganz

Co-amorphous systems have been shown to be a promising strategy to address the poor water solubility of many drug candidates. However, little is known about the effect of downstream processing-induced stress on these systems. The aim of this study is...

(This article belongs to the Special Issue Amorphous Drug Formulations: Progress, Challenges and Perspectives)
  • Article
  • Open Access
15 Citations
5,254 Views
18 Pages

Downstream Processing of Amorphous and Co-Amorphous Olanzapine Powder Blends

  • Nuno F. da Costa,
  • Rolf Daniels,
  • Ana I. Fernandes and
  • João F. Pinto

The work evaluates the stability of amorphous and co-amorphous olanzapine (OLZ) in tablets manufactured by direct compression. The flowability and the compressibility of amorphous and co-amorphous OLZ with saccharin (SAC) and the properties of the ta...

(This article belongs to the Special Issue Advances in Pharmaceutical Solid Forms)
  • Feature Paper
  • Article
  • Open Access
28 Citations
5,367 Views
12 Pages

Preparation of Co-Amorphous Systems by Freeze-Drying

  • Melvin Wostry,
  • Hanna Plappert and
  • Holger Grohganz

Freeze-drying was evaluated as a production technique for co-amorphous systems of a poorly water-soluble drug. Naproxen was freeze-dried together with arginine and lysine as co-former. To increase the solubility of naproxen in the starting solution,...

(This article belongs to the Special Issue Pharmaceutical Freeze Drying and Spray Drying)
  • Article
  • Open Access
4 Citations
2,131 Views
17 Pages

Mechanistic Investigation into Crystallization of Hydrated Co-Amorphous Systems of Flurbiprofen and Lidocaine

  • Xiaoyue Xu,
  • Holger Grohganz,
  • Justyna Knapik-Kowalczuk,
  • Marian Paluch and
  • Thomas Rades

Background: It is generally accepted that water as a plasticizer can decrease the glass transition temperatures (Tgs) of amorphous drugs and drug delivery systems, resulting in physical instabilities. However, a recent study has reported an anti-plas...

(This article belongs to the Special Issue Advances in the Preparation and Technology of Pharmaceutical Solid Dosage Forms)
  • Article
  • Open Access
43 Citations
10,564 Views
17 Pages

Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying

  • Goedele Craye,
  • Korbinian Löbmann,
  • Holger Grohganz,
  • Thomas Rades and
  • Riikka Laitinen

3 December 2015

In this study, spray drying from aqueous solutions, using the surface-active agent sodium lauryl sulfate (SLS) as a solubilizer, was explored as a production method for co-amorphous simvastatin–lysine (SVS-LYS) at 1:1 molar mixtures, which previously...

(This article belongs to the Collection Poorly Soluble Drugs)
  • Article
  • Open Access
3 Citations
1,755 Views
14 Pages

Co-Amorphous Andrographolide–Lysine with Unexpectedly Enhanced Solubility

  • Haifeng Luo,
  • Yuchen Zheng,
  • Shizhao Ren,
  • Wangchuan Xiao and ,
  • Rongrong Xue,
  • Wei Han and
  • Fenghua Chen
  • + 2 authors+ 0 author

25 August 2025

Andrographolide (ADG) is a typical poorly water-soluble drug, and a co-amorphous strategy was used here to improve its aqueous solubility. Co-amorphous systems of ADG and amino acids with a 1:1 molar ratio were screened via the neat ball milling meth...

  • Proceeding Paper
  • Open Access
2 Citations
2,577 Views
3 Pages

The evaluation of the processability of co-amorphous mixtures is of paramount importance since these systems are increasingly used to address the poor solubility presented by most of the drugs in research and development. This work shows that co-amor...

(This article belongs to the Proceedings of The 5th International Congress of CiiEM (IC CiiEM))
  • Article
  • Open Access
36 Citations
7,465 Views
13 Pages

Influence of Solvent Composition on the Performance of Spray-Dried Co-Amorphous Formulations

  • Jaya Mishra,
  • Thomas Rades,
  • Korbinian Löbmann and
  • Holger Grohganz

Ball-milling is usually used to prepare co-amorphous drug–amino acid (AA) mixtures. In this study, co-amorphous drug–AA mixtures were produced using spray-drying, a scalable industrially preferred preparation method. The influence of the solvent type...

(This article belongs to the Special Issue Dissolution Enhancement of Poorly Soluble Drugs)
  • Article
  • Open Access
29 Citations
6,971 Views
16 Pages

A Novel Desloratadine-Benzoic Acid Co-Amorphous Solid: Preparation, Characterization, and Stability Evaluation

  • Ahmad Ainurofiq,
  • Rachmat Mauludin,
  • Diky Mudhakir and
  • Sundani Nurono Soewandhi

Low physical stability is the limitation of the widespread use of amorphous drugs. The co-amorphous drug system is a new and emerging method for preparing a stable amorphous form. Co-amorphous is a single-phase amorphous multicomponent system consist...

  • Review
  • Open Access
217 Citations
25,567 Views
26 Pages

The amorphous solid state offers an improved apparent solubility and dissolution rate. However, due to thermodynamic instability and recrystallization tendencies during processing, storage and dissolution, their potential application is limited. For...

(This article belongs to the Special Issue Dissolution Enhancement of Poorly Soluble Drugs)
  • Article
  • Open Access
655 Views
26 Pages

Relaxation Polyamorphism of Rosuvastatin and Physicochemical Characterisation of a Rosuvastatin–Carvedilol Co-Amorphous System

  • Agata Olszewska,
  • Maria Brycka,
  • Anita Umerska,
  • Lidia Tajber and ,
  • Marek Pyda and
  • Marcin Skotnicki
  • + 1 author+ 0 author

Objective: In this study, the solid-state properties of two amorphous forms of rosuvastatin calcium (ROS) and co-amorphous systems of rosuvastatin with carvedilol (CAR) were investigated. Methods: The studied systems were investigated using TGA, DSC,...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Article
  • Open Access
8 Citations
4,057 Views
20 Pages

6 September 2022

The preparation of amorphous and co-amorphous systems (CAMs) effectively addresses the solubility and bioavailability issues of poorly water-soluble chemical entities. However, stress conditions imposed during common pharmaceutical processing (e.g.,...

(This article belongs to the Collection Feature Papers in Materials Science)
  • Article
  • Open Access
35 Citations
7,590 Views
13 Pages

28 August 2018

The high index of simultaneous incidence of hypertension and hypercholesterolemia in the population of many countries demands the preparation of more efficient drugs. Therefore, there is a significant area of opportunity to provide as many alternativ...

(This article belongs to the Collection Poorly Soluble Drugs)
  • Article
  • Open Access
14 Citations
3,331 Views
11 Pages

Preparation and Characterization of Lutein Co-Amorphous Formulation with Enhanced Solubility and Dissolution

  • Xuening Song,
  • Yingting Luo,
  • Wenduo Zhao,
  • Simiao Liu and ,
  • Yuzhuo Wang and
  • Hao Zhang
  • + 1 author+ 0 author

26 June 2024

Lutein is an oxygenated fat-soluble carotenoid and a functional compound with proven health benefits for the human body. Nevertheless, the poor water solubility and low oral bioavailability of lutein greatly limit its application. To address this, we...

(This article belongs to the Section Food Nutrition)
  • Article
  • Open Access
22 Citations
4,188 Views
18 Pages

Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs

  • Marika Ruponen,
  • Konsta Kettunen,
  • Monica Santiago Pires and
  • Riikka Laitinen

In this study, the amino acid arginine (ARG) and P-glycoprotein (P-gp) inhibitors verapamil hydrochloride (VER), piperine (PIP) and quercetin (QRT) were used as co-formers for co-amorphous mixtures of a Biopharmaceutics classification system (BCS) cl...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Article
  • Open Access
46 Citations
10,925 Views
11 Pages

Co-amorphous drug–drug systems have been developed with the overall aim of improving the physical stability of two or more amorphous drugs. Co-amorphous systems often show good physical stability, and higher solubility and dissolution rates com...

(This article belongs to the Special Issue Advances in Amorphous Drug Formulations)
  • Article
  • Open Access
14 Citations
3,309 Views
15 Pages

Preparation of Co-Amorphous Levofloxacin Systems for Pulmonary Application

  • Aljoscha Gabelmann,
  • Claus-Michael Lehr and
  • Holger Grohganz

Addressing antimicrobial resistance requires new approaches in various disciplines of pharmaceutical sciences. The fluoroquinolone levofloxacin (LEV) plays an important role in the therapy of lung infections. However, its effectiveness is limited by...

(This article belongs to the Special Issue Pharmaceutical Freeze Drying and Spray Drying, Volume II)
  • Article
  • Open Access
130 Citations
12,454 Views
20 Pages

Improving Co-Amorphous Drug Formulations by the Addition of the Highly Water Soluble Amino Acid, Proline

  • Katrine Tarp Jensen,
  • Korbinian Löbmann,
  • Thomas Rades and
  • Holger Grohganz

Co-amorphous drug amino acid mixtures were previously shown to be a promising approach to create physically stable amorphous systems with the improved dissolution properties of poorly water-soluble drugs. The aim of this work was to expand the co-am...

  • Article
  • Open Access
32 Citations
4,852 Views
13 Pages

Sustained Release of Co-Amorphous Matrine-Type Alkaloids and Resveratrol with Anti-COVID-19 Potential

  • Dandan Hu,
  • Xin Chen,
  • Duanxiu Li,
  • Hailu Zhang and ,
  • Yanwen Duan and
  • Yong Huang
  • + 1 author+ 0 author

Matrine (MAR), oxymatrine (OMAR), and sophoridine (SPD) are natural alkaloids with varying biological activities; matrine was recently used for the treatment of coronavirus disease 2019 (COVID-19). However, the short half-lives and rapid elimination...

(This article belongs to the Section Drug Delivery and Controlled Release)
  • Article
  • Open Access
9 Citations
9,008 Views
17 Pages

Multivariate Quantification of the Solid State Phase Composition of Co-Amorphous Naproxen-Indomethacin

  • Andreas Beyer,
  • Holger Grohganz,
  • Korbinian Löbmann,
  • Thomas Rades and
  • Claudia S. Leopold

27 October 2015

To benefit from the optimized dissolution properties of active pharmaceutical ingredients in their amorphous forms, co-amorphisation as a viable tool to stabilize these amorphous phases is of both academic and industrial interest. Reports dealing wit...

(This article belongs to the Collection Poorly Soluble Drugs)
  • Proceeding Paper
  • Open Access
1,200 Views
1 Page

1 December 2020

Most new low molecular weight chemical entities in pharmaceutical developments suffer from a low aqueous solubility, making oral delivery challenging. Despite the numerous formulation efforts that can be investigated, research especially on amorphous...

(This article belongs to the Proceedings of The 1st International Electronic Conference on Pharmaceutics)
  • Article
  • Open Access
38 Citations
4,305 Views
19 Pages

Sinapic Acid Co-Amorphous Systems with Amino Acids for Improved Solubility and Antioxidant Activity

  • Ewa Garbiec,
  • Natalia Rosiak,
  • Ewa Tykarska,
  • Przemysław Zalewski and
  • Judyta Cielecka-Piontek

The objective of this study was to obtain co-amorphous systems of poorly soluble sinapic acid using amino acids as co-formers. In order to assess the probability of the interaction of amino acids, namely, arginine, histidine, lysine, tryptophan, and...

(This article belongs to the Special Issue Small Molecule Drug Design and Research 2.0)
  • Article
  • Open Access
10 Citations
3,295 Views
22 Pages

Transdermal administration can be considered as an interesting route to overcome the side-effects inherent to oral intake. Designing topical formulations with maximum drug efficiency requires the optimization of the permeation and the stability of th...

(This article belongs to the Special Issue Amorphous Drug Formulations: Progress, Challenges and Perspectives)
  • Article
  • Open Access
38 Citations
6,153 Views
20 Pages

Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy

  • Marcin Skotnicki,
  • Barbara Jadach,
  • Agnieszka Skotnicka,
  • Bartłomiej Milanowski and ,
  • Lidia Tajber,
  • Marek Pyda and
  • Jacek Kujawski
  • + 2 authors+ 0 author

The aim of this study was to characterize a 1:1 molar ratio of a pharmacologically relevant co-amorphous atorvastatin-irbesartan (ATR-IRB) system obtained by quench cooling of the crystalline ATR/IRB physical mixture for potential use in the fixed-do...

(This article belongs to the Special Issue Impact of Physicochemical Properties of Pharmaceutical Substances on Dosage Form Performance)
  • Article
  • Open Access
8 Citations
3,990 Views
10 Pages

Development of Co-Amorphous Loratadine–Citric Acid Orodispersible Drug Formulations

  • Emőke Margit Rédai,
  • Emese Sipos,
  • Robert Alexandru Vlad,
  • Paula Antonoaea and ,
  • Nicoleta Todoran and
  • Adriana Ciurba
  • + 1 author+ 0 author

16 December 2022

This study aimed at the preparation and characterization of co-amorphous loratadine–citric acid orally disintegrating dosage forms (ODx). A co-amorphous loratadine–citric acid was prepared by solvent evaporation method in three different...

(This article belongs to the Section Pharmaceutical Processes)
  • Article
  • Open Access
24 Citations
5,429 Views
11 Pages

Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations

  • Georgia Kasten,
  • Íris Duarte,
  • Maria Paisana,
  • Korbinian Löbmann and ,
  • Thomas Rades and
  • Holger Grohganz
  • + 1 author+ 0 author

The feasibility of upscaling the formulation of co-amorphous indomethacin-lysine from lab-scale to pilot-scale spray drying was investigated. A 22 full factorial design of experiments (DoE) was employed at lab scale. The atomization gas flow rate (Fa...

(This article belongs to the Special Issue Feature Papers for 10th Anniversary of Pharmaceutics)
  • Article
  • Open Access
18 Citations
4,611 Views
17 Pages

Brick dust molecules are usually poorly soluble in water and lipoidal components, making it difficult to formulate them in dosage forms that provide efficient pharmacological effects. A co-amorphous system is an effective strategy to resolve these is...

(This article belongs to the Special Issue Recent Progress in Formulation Approaches for Improving the Solubility and Bioavailability of Poorly Soluble Drugs)
  • Article
  • Open Access
55 Citations
4,614 Views
23 Pages

Deaggregation and Crystallization Inhibition by Small Amount of Polymer Addition for a Co-Amorphous Curcumin-Magnolol System

  • Jiawei Han,
  • Luyuan Li,
  • Meiling Su,
  • Weili Heng and ,
  • Yuanfeng Wei,
  • Yuan Gao and
  • Shuai Qian
  • + 2 authors+ 0 author

Different from previously reported co-amorphous systems, a co-amorphous curcumin-magnolol (CUR-MAG CM) system, as compared with its crystalline counterparts, exhibited decreased dissolution due to its aggregation during dissolution. The main purpose...

  • Article
  • Open Access
35 Citations
6,408 Views
14 Pages

Co-Amorphous Screening for the Solubility Enhancement of Poorly Water-Soluble Mirabegron and Investigation of Their Intermolecular Interactions and Dissolution Behaviors

  • Ji-Hun An,
  • Changjin Lim,
  • Alice Nguvoko Kiyonga,
  • In Hwa Chung and ,
  • In Kyu Lee,
  • Kilwoong Mo,
  • Minho Park,
  • Wonno Youn,
  • Won Rak Choi and
  • Kiwon Jung
  • + 6 authors+ 1 author

In the present study, the screening of Mirabegron (MBR) co-amorphous was performed to produce water-soluble and thermodynamically stable MBR co-amorphous with the purpose of overcoming the water solubility problem of MBR. MBR is Biopharmaceutics Clas...

  • Article
  • Open Access
3 Citations
3,207 Views
19 Pages

In Situ Co-Amorphization of Olanzapine in the Matrix and on the Coat of Pellets

  • Nuno F. da Costa,
  • Raquel F. Azevedo,
  • João A. Lopes,
  • Ana I. Fernandes and
  • João F. Pinto

In situ amorphization is a promising approach, considered in the present work, to enhance the solubility and dissolution rate of olanzapine, while minimizing the exposure of the amorphous material to the stress conditions applied during conventional...

(This article belongs to the Special Issue Applications of Crystal Engineering in Drug Delivery)
  • Article
  • Open Access
523 Views
22 Pages

Selective Co-Crystallization and Co-Amorphous Formation of Flavanones from Licorice Leaves

  • Alessandra Crispini,
  • Francesca Aiello and
  • Francesca Scarpelli

1 May 2026

Flavanones retrieved in the leaves of Glycyrrhiza glabra (licorice), specifically glabranin (GLA), pinocembrin (PIN) and licoflavanone (LIC), represent a valuable source of bioactive natural products, although their isolation and handling are often c...

(This article belongs to the Section Crystal Engineering)
  • Article
  • Open Access
4 Citations
3,210 Views
17 Pages

Background/Objectives: Brick dust molecules exhibit high melting points and ultralow solubility. Overcoming this solubility issue is challenging. Previously, we formulated a co-amorphous system for a neuropeptide Y5 receptor antagonist (NP) as a bric...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Article
  • Open Access
444 Views
15 Pages

11 August 2026

This study investigated the formation of a co-amorphous complex between ursolic acid and quercetin as a chemically defined model system for improving the formulation performance of a poorly soluble triterpenoid acid. Co-amorphous systems were prepare...

(This article belongs to the Special Issue Bioactive Compounds of Aromatic Plants and Their Applications)
  • Article
  • Open Access
17 Citations
4,448 Views
8 Pages

4 February 2021

Converting crystalline compounds into co-amorphous systems is an effective way to improve the solubility of poorly water-soluble drugs. It is, however, of critical importance for the physical stability of co-amorphous systems to find the optimal mixi...

(This article belongs to the Collection Poorly Soluble Drugs)
  • Article
  • Open Access
2 Citations
2,266 Views
20 Pages

20 November 2024

The objective of this work was to improve the solubility and discover a stable co-amorphous form of valsartan (VAL), a BCS class-II drug, by utilizing small molecule 2-Aminopyridine (2-AP) in varying molar ratios (2:1, 1:1, and 1:2), employing a solv...

  • Article
  • Open Access
29 Citations
3,709 Views
25 Pages

Genistein Co-Amorphous Systems with Amino Acids: An Investigation into Enhanced Solubility and Biological Activity

  • Ewa Garbiec,
  • Natalia Rosiak,
  • Przemysław Zalewski,
  • Lidia Tajber and
  • Judyta Cielecka-Piontek

Genistein, an isoflavone known for its antioxidant and antidiabetic effects, suffers from the drawback of low solubility. To overcome this limitation, co-amorphous systems were synthesized by incorporating amino acids that were chosen through computa...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Article
  • Open Access
17 Citations
5,894 Views
17 Pages

Data-Driven Prediction of the Formation of Co-Amorphous Systems

  • Elisabeth Fink,
  • Michael Brunsteiner,
  • Stefan Mitsche,
  • Hartmuth Schröttner and ,
  • Amrit Paudel and
  • Sarah Zellnitz-Neugebauer
  • + 1 author+ 0 author

Co-amorphous systems (COAMS) have raised increasing interest in the pharmaceutical industry, since they combine the increased solubility and/or faster dissolution of amorphous forms with the stability of crystalline forms. However, the choice of the...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Article
  • Open Access
22 Citations
5,578 Views
13 Pages

Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy

  • Adam Bohr,
  • Thais Leite Nascimento,
  • Necati Harmankaya,
  • Johan Juhl Weisser and ,
  • Yingya Wang,
  • Holger Grohganz,
  • Thomas Rades and
  • Korbinian Löbmann
  • + 3 authors+ 0 author

11 January 2019

Many anti-cancer drugs are difficult to formulate into an oral dosage form because they are both poorly water-soluble and show poor permeability, the latter often as a result of being an intestinal efflux pump substrate. To obtain a more water-solubl...

(This article belongs to the Collection Poorly Soluble Drugs)
  • Review
  • Open Access
11 Citations
3,358 Views
26 Pages

Cutting-Edge Approaches in the Co-Amorphization Process

  • Azza A. K. Mahmoud,
  • Géza Regdon and
  • Katalin Kristó

Background: Recently, the co-amorphization method has been widely used to refine the bioavailability characteristics of poorly soluble drugs in addition to overcoming the drawbacks of other traditional amorphization techniques. Objectives: The main a...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Article
  • Open Access
10 Citations
1,638 Views
16 Pages

Mechanistic Insight into the Enhanced Anti-Pulmonary Hypertension Efficacy of Wogonin Co-Amorphous

  • Zhongshui Xie,
  • Yucai Chen,
  • Jiaqi Xie,
  • Yan Lei and ,
  • Chunxue Jia,
  • Yulu Liang,
  • Hongjuan Wang and
  • Jianmei Huang
  • + 3 authors+ 0 author

Background: Pulmonary hypertension (PH) remains a life-threatening rare disease characterized by inflammation and oxidative stress in pulmonary artery smooth muscle cells (PASMCs). Wogonin (Wog), a plant-derived polyphenolic compound extracted from S...

(This article belongs to the Special Issue Pharmaceutical Polymorphs and Cocrystals and Their In Vitro and In Vivo Evaluation)
  • Article
  • Open Access
10 Citations
5,375 Views
24 Pages

Development of a Novel Co-Amorphous Curcumin and L-Arginine (1:2): Structural Characterization, Biological Activity and Pharmacokinetics

  • Jose Antonio Mancillas-Quiroz,
  • Miriam del Carmen Carrasco-Portugal,
  • Karina Mondragón-Vásquez,
  • Juan Carlos Huerta-Cruz and ,
  • Juan Rodríguez-Silverio,
  • Leyanis Rodríguez-Vera,
  • Juan Gerardo Reyes-García,
  • Francisco Javier Flores-Murrieta,
  • Jorge Guillermo Domínguez-Chávez and
  • Héctor Isaac Rocha-González
  • + 5 authors+ 0 author

Background: Curcumin appears to be well tolerated and effective for managing chronic inflammatory pain, but its poor oral bioavailability has been a hurdle in its use as a therapeutic agent. The current study was performed to characterize a novel co-...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Review
  • Open Access
163 Citations
14,578 Views
43 Pages

Co-amorphous drug delivery systems (CAMS) are characterized by the combination of two or more (initially crystalline) low molecular weight components that form a homogeneous single-phase amorphous system. Over the past decades, CAMS have been widely...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Article
  • Open Access
10 Citations
4,150 Views
14 Pages

Solid–Liquid Equilibrium in Co-Amorphous Systems: Experiment and Prediction

  • Alžběta Zemánková,
  • Fatima Hassouna,
  • Martin Klajmon and
  • Michal Fulem

In this work, the solid–liquid equilibrium (SLE) of four binary systems combining two active pharmaceutical ingredients (APIs) capable of forming co-amorphous systems (CAMs) was investigated. The binary systems studied were naproxen-indomethaci...

(This article belongs to the Special Issue Exclusive Feature Papers in Physical Chemistry)
  • Article
  • Open Access
9 Citations
1,885 Views
18 Pages

Development of Co-Amorphous Systems for Inhalation Therapy—Part 1: From Model Prediction to Clinical Success

  • Eleonore Fröhlich,
  • Aurora Bordoni,
  • Nila Mohsenzada,
  • Stefan Mitsche and ,
  • Hartmuth Schröttner and
  • Sarah Zellnitz-Neugebauer
  • + 1 author+ 0 author

Background/Objectives: The integration of machine learning (ML) and artificial intelligence (AI) has revolutionized the pharmaceutical industry by improving drug discovery, development and manufacturing processes. Based on literature data, an ML mode...

(This article belongs to the Section Drug Targeting and Design)
  • Article
  • Open Access
4 Citations
1,312 Views
24 Pages

Development of Co-Amorphous Systems for Inhalation Therapy—Part 2: In Silico Guided Co-Amorphous Rifampicin–Moxifloxacin and –Ethambutol Formulations

  • Eleonore Fröhlich,
  • Noon Sharafeldin,
  • Valerie Reinisch,
  • Nila Mohsenzada and ,
  • Stefan Mitsche,
  • Hartmuth Schröttner and
  • Sarah Zellnitz-Neugebauer
  • + 2 authors+ 0 author

Background/Objectives: Tuberculosis (TB) remains a global health challenge due to long treatment durations, poor adherence, and growing drug resistance. Inhalable co-amorphous systems (COAMS) offer a promising strategy for targeted pulmonary delivery...

(This article belongs to the Section Drug Targeting and Design)
  • Article
  • Open Access
3 Citations
2,507 Views
14 Pages

Using co-amorphous systems (CAMS) has shown promise in addressing the challenges associated with poorly water-soluble drugs. Quench-cooling is a commonly used CAMS preparation method, often followed by grinding or milling to achieve a fine powder tha...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Article
  • Open Access
33 Citations
8,787 Views
13 Pages

Long-Term Stability of New Co-Amorphous Drug Binary Systems: Study of Glass Transitions as a Function of Composition and Shelf Time

  • Luz María Martínez,
  • Marcelo Videa,
  • Nahida González Sosa,
  • José Héctor Ramírez and
  • Samuel Castro

14 December 2016

The amorphous state is of particular interest in the pharmaceutical industry due to the higher solubility that amorphous active pharmaceutical ingredients show compared to their respective crystalline forms. Due to their thermodynamic instability, dr...

(This article belongs to the Collection Poorly Soluble Drugs)
  • Article
  • Open Access
8 Citations
3,848 Views
23 Pages

The Effects of Novel Co-Amorphous Naringenin and Fisetin Compounds on a Diet-Induced Obesity Murine Model

  • Sarai Vásquez-Reyes,
  • Miranda Bernal-Gámez,
  • Jorge Domínguez-Chávez,
  • Karina Mondragón-Vásquez and ,
  • Mónica Sánchez-Tapia,
  • Guillermo Ordaz,
  • Omar Granados-Portillo,
  • Diana Coutiño-Hernández,
  • Paulina Barrera-Gómez and
  • Armando R. Tovar
  • + 6 authors+ 1 author

23 December 2024

Background/Objective: In recent studies, it has been shown that dietary bioactive compounds can produce health benefits; however, it is not known whether an improvement in solubility can enhance their biological effects. Thus, the aim of this work wa...

(This article belongs to the Section Nutrition and Obesity)
  • Article
  • Open Access
1 Citations
1,945 Views
15 Pages

Background/Objectives: The poor aqueous solubility of curcumin (CUR) limits its pharmaceutical application. Although amorphization can enhance its solubility, the amorphous form often exhibits insufficient physical stability. Co-amorphization, partic...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Article
  • Open Access
23 Citations
5,376 Views
19 Pages

Co-Amorphization of Kanamycin with Amino Acids Improves Aerosolization

  • Bishal Raj Adhikari,
  • Kārlis Bērziņš,
  • Sara J. Fraser-Miller,
  • Keith C. Gordon and
  • Shyamal C. Das

Different formulation techniques have been investigated to prepare highly aerosolizable dry powders to deliver a high dose of antibiotics to the lung for treating local infections. In this study, we investigated the influence of the co-amorphization...

(This article belongs to the Special Issue Advances in Amorphous Drug Formulations)

of 24